358 related articles for article (PubMed ID: 31977267)
1. Dentoalveolar Defects in the
Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
[TBL] [Abstract][Full Text] [Related]
2. Effects of Active Vitamin D or FGF23 Antibody on
Lira Dos Santos EJ; Chavez MB; Tan MH; Mohamed FF; Kolli TN; Foster BL; Liu ES
J Dent Res; 2021 Dec; 100(13):1482-1491. PubMed ID: 33906518
[TBL] [Abstract][Full Text] [Related]
3. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Baroukh B; Slimani L; Sadoine J; Penel G; Biosse-Duplan M; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Bone; 2017 Oct; 103():334-346. PubMed ID: 28764922
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
6. Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse.
Fong H; Chu EY; Tompkins KA; Foster BL; Sitara D; Lanske B; Somerman MJ
J Periodontol; 2009 Aug; 80(8):1348-54. PubMed ID: 19656036
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).
Carpenter KA; Alkhatib DO; Dulion BA; Guirado E; Patel S; Chen Y; George A; Ross RD
Int J Oral Sci; 2023 Oct; 15(1):47. PubMed ID: 37813865
[TBL] [Abstract][Full Text] [Related]
8. Impaired mineral quality in dentin in X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Penel G; Schmitt A; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Connect Tissue Res; 2018 Dec; 59(sup1):91-96. PubMed ID: 29745817
[TBL] [Abstract][Full Text] [Related]
9. Conductive Hearing Loss in the Hyp Mouse Model of X-Linked Hypophosphatemia Is Accompanied by Hypomineralization of the Auditory Ossicles.
Delsmann MM; Seist R; Stürznickel J; Schmidt FN; Mansour A; Kobelski MM; Broocks G; Peichl J; Oheim R; Praetorius M; Schinke T; Amling M; Demay MB; Stankovic KM; Rolvien T
J Bone Miner Res; 2021 Dec; 36(12):2317-2328. PubMed ID: 34523743
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
[TBL] [Abstract][Full Text] [Related]
11. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
[TBL] [Abstract][Full Text] [Related]
12. Cementocyte alterations associated with experimentally induced cellular cementum apposition in Hyp mice.
Lira Dos Santos EJ; Salmon CR; Chavez MB; de Almeida AB; Tan MH; Chu EY; Sallum EA; Casati MZ; Ruiz KGS; Kantovitz KR; Foster BL; Nociti Júnior FH
J Periodontol; 2021 Nov; 92(11):116-127. PubMed ID: 34003518
[TBL] [Abstract][Full Text] [Related]
13. Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia.
Lira Dos Santos EJ; Nakajima K; Po J; Hanai A; Zhukouskaya V; Biosse Duplan M; Linglart A; Shimada T; Chaussain C; Bardet C
Int J Oral Sci; 2023 Dec; 15(1):53. PubMed ID: 38052774
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin antibody improves alveolar bone quality in the
Ross R; Carpenter K; Alkhatib D; Dulion B; Guirado E; Patel S; Chen Y; George A
Res Sq; 2023 Apr; ():. PubMed ID: 37090634
[TBL] [Abstract][Full Text] [Related]
15. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
[TBL] [Abstract][Full Text] [Related]
16. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.
Coyac BR; Hoac B; Chafey P; Falgayrac G; Slimani L; Rowe PS; Penel G; Linglart A; McKee MD; Chaussain C; Bardet C
J Dent Res; 2018 Feb; 97(2):184-191. PubMed ID: 28880715
[TBL] [Abstract][Full Text] [Related]
17. SPR4-peptide alters bone metabolism of normal and HYP mice.
Zelenchuk LV; Hedge AM; Rowe PS
Bone; 2015 Mar; 72():23-33. PubMed ID: 25460577
[TBL] [Abstract][Full Text] [Related]
18. Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.
Tokarz D; Martins JS; Petit ET; Lin CP; Demay MB; Liu ES
J Bone Miner Res; 2018 Mar; 33(3):499-509. PubMed ID: 29083055
[TBL] [Abstract][Full Text] [Related]
19. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
20. Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice.
Zhang B; Sun Y; Chen L; Guan C; Guo L; Qin C
Oral Dis; 2010 Jul; 16(5):453-64. PubMed ID: 20233318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
